Clinical Trial Update: Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of nivolumab and metformin in treatment-refractory metastatic microsatellite-stable colorectal cancer has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Glucophage (metformin) (metformin)
• Opdivo (nivolumab) (nivolumab)

Snippet

Sponsor: Emory University | Conditions: Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-09-05